New drugs for early Alzheimer’s disease may allow people to live without help for up to 39 additional months, a new study estimates. But experts urge caution.

Last week, the non-partisan not-for-profit Doctors for America (DFA) filed a lawsuit alleging the FDA, CDC, Office of ...

The Senate on Thursday confirmed Robert F. Kennedy Jr. to lead the Department of Health and Human Services, voting to approve ...

In an effort to prevent prescription drug misuse, Community Connections will be providing free at-home drug “deactivation and ...

The rise of misinformation online has helped fringe health ideas go mainstream and eased RFK Jr.'s path to confirmation as ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...

A generation has passed since the peak in AIDS-related deaths. Few people under 30 years old understand what AIDS does to the ...

The Independent Data Monitoring Committee met this week on February 10, 2025 to evaluate the unblinded safety Phase 2b QUALITY data and recommended to continue the QUALITY extension study as designed- ...

Columnist Teri Sforza writes that childhood obesity in California is on the rise, state data shows. Free school meals have ...

Some public health data targeted by Trump’s executive orders has been restored, but what’s changed and how will that affect health policy?